Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses
Overview
Affiliations
Adenosine deaminases acting on double-stranded RNA (ADARs) catalyze the deamination of adenosine (A) to produce inosine (I) in double-stranded (ds) RNA structures, a process known as A-to-I RNA editing. dsRNA is an important trigger of innate immune responses, including interferon (IFN) production and action. We examined the role of A-to-I RNA editing by two ADARs, ADAR1 and ADAR2, in the sensing of self-RNA in the absence of pathogen infection, leading to activation of IFN-induced, RNA-mediated responses in mouse embryo fibroblasts. IFN treatment of Adar1(-/-) cells lacking both the p110 constitutive and p150 IFN-inducible ADAR1 proteins induced formation of stress granules, whereas neither wild-type (WT) nor Adar2(-/-) cells displayed a comparable stress granule response following IFN treatment. Phosphorylation of protein synthesis initiation factor eIF2α at serine 51 was increased in IFN-treated Adar1(-/-) cells but not in either WT or Adar2(-/-) cells following IFN treatment. Analysis by deep sequencing of mouse exonic loci containing A-to-I-editing sites revealed that the majority of editing in mouse embryo fibroblasts was carried out by ADAR1. IFN treatment increased editing in both WT and Adar2(-/-) cells but not in either Adar1(-/-) or Adar1(-/-) (p150) cells or Stat1(-/-) or Stat2(-/-) cells. Hyper-edited sites found in predicted duplex structures showed strand bias of editing for some RNAs. These results implicate ADAR1 p150 as the major A-to-I editor in mouse embryo fibroblasts, acting as a feedback suppressor of innate immune responses otherwise triggered by self-RNAs possessing regions of double-stranded character.
inositol hexaphosphate pathways couple to RNA interference and pathogen defense.
Xu W, Sun Y, Breen P, Ruvkun G, Mao K Proc Natl Acad Sci U S A. 2024; 121(49):e2416982121.
PMID: 39602251 PMC: 11626161. DOI: 10.1073/pnas.2416982121.
Charting and probing the activity of ADARs in human development and cell-fate specification.
Dailamy A, Lyu W, Nourreddine S, Tong M, Rainaldi J, McDonald D Nat Commun. 2024; 15(1):9818.
PMID: 39537590 PMC: 11561244. DOI: 10.1038/s41467-024-53973-0.
Zak H, Rozenfeld E, Levi M, Deng P, Gorelick D, Pozeilov H Sci Adv. 2024; 10(36):eadi9101.
PMID: 39231215 PMC: 11373593. DOI: 10.1126/sciadv.adi9101.
RNA editing regulates host immune response and T cell homeostasis in SARS-CoV-2 infection.
Huang M, Mark A, Pham J, Vera K, Saravia-Butler A, Beheshti A PLoS One. 2024; 19(8):e0307450.
PMID: 39178184 PMC: 11343423. DOI: 10.1371/journal.pone.0307450.
RNA editing and immune control: from mechanism to therapy.
Hu S, Li J Curr Opin Genet Dev. 2024; 86:102195.
PMID: 38643591 PMC: 11162905. DOI: 10.1016/j.gde.2024.102195.